Christopher J. Scoggins, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 414 shares at $96.10 ($40K) on 2020-04-21, disclosed to the SEC on 2020-04-23.
Scheduled sale ($40k) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |